GB Patent
GB2184122B — N,n-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methyl butylamine hydrochloride monohydrate
Assigned to Boots Co PLC · Expires 1989-10-18 · 37y expired
What this patent protects
Patent listed against Bylvay.
Drugs covered by this patent
- Bylvay (ODEVIXIBAT) · Ipsen
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.